T. Rowe Price Associates’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50M Buy
91,866
+35,211
+62% +$14.4M 0.01% 768
2025
Q4
$17.8M Buy
56,655
+9,926
+21% +$3.15M ﹤0.01% 1082
2025
Q3
$12.6M Buy
46,729
+29,168
+166% +$6.68M ﹤0.01% 1169
2025
Q2
$3.87M Sell
17,561
-2,287
-12% -$412K ﹤0.01% 1361
2025
Q1
$2.6M Sell
19,848
-11,230
-36% -$1.57M ﹤0.01% 1497
2024
Q4
$4.26M Buy
31,078
+4,341
+16% +$596K ﹤0.01% 1331
2024
Q3
$2.71M Buy
26,737
+21,195
+382% +$1.68M ﹤0.01% 1499
2024
Q2
$406K Sell
5,542
-114
-2% -$7.47K ﹤0.01% 2275
2024
Q1
$286K Buy
5,656
+539
+11% +$25.3K ﹤0.01% 2453
2023
Q4
$240K Sell
5,117
-476
-9% -$21.7K ﹤0.01% 2469
2023
Q3
$255K Buy
5,593
+272
+5% +$11.2K ﹤0.01% 2407
2023
Q2
$210K Buy
5,321
+181
+4% +$7.32K ﹤0.01% 2513
2023
Q1
$209K Buy
+5,140
New +$202K ﹤0.01% 2508

Other funds holding AGX

T. Rowe Price Associates's AGX Position: Q1 2026 in Review

T. Rowe Price Associates increased its Argan (AGX) stake by 62% in Q1 2026, buying an estimated $14.4M and bringing the position to 91,866 shares worth $50M. The position accounts for 0.01% of the portfolio, ranked #768.

T. Rowe Price Associates first reported a position in AGX in Q1 2023 and has held it in 13 quarters since. 495 funds tracked by Wall St. Rank hold AGX as of Q1 2026.

  • T. Rowe Price Associates held 91,866 shares of Argan worth $50M as of Q1 2026.
  • T. Rowe Price Associates bought 35,211 Argan shares in Q1 2026, an estimated $14.4M.
  • Argan made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #768 holding.
  • T. Rowe Price Associates first reported a position in Argan in Q1 2023 and has held it in 13 quarters since.
  • 495 funds tracked by Wall St. Rank held Argan as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.